Clearbridge Investments LLC Has $27.03 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Clearbridge Investments LLC lessened its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 13.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 293,997 shares of the medical device company's stock after selling 44,912 shares during the quarter. Clearbridge Investments LLC owned 0.15% of Cooper Companies worth $27,027,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in COO. Norges Bank bought a new stake in shares of Cooper Companies during the fourth quarter worth $217,906,000. Raymond James Financial Inc. acquired a new position in Cooper Companies in the 4th quarter worth $64,826,000. Victory Capital Management Inc. increased its holdings in Cooper Companies by 14.6% during the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after purchasing an additional 574,899 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock valued at $543,979,000 after purchasing an additional 573,908 shares during the period. Finally, Wealthfront Advisers LLC lifted its holdings in shares of Cooper Companies by 4,594.1% in the fourth quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company's stock valued at $52,383,000 after purchasing an additional 557,673 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Performance

NASDAQ COO traded down $4.40 on Friday, hitting $73.77. 2,661,526 shares of the stock were exchanged, compared to its average volume of 1,367,710. The company has a market capitalization of $14.75 billion, a PE ratio of 37.83, a P/E/G ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The business's fifty day moving average is $87.76 and its 200 day moving average is $96.14. The Cooper Companies, Inc. has a 52 week low of $73.34 and a 52 week high of $112.38.

Remove Ads

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Stifel Nicolaus decreased their price objective on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Citigroup decreased their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Finally, Robert W. Baird lowered their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.